Dr. Sofia Horvath, MD

Dr. Horvath practices at Mount Sinai Medical Center - Hialeah Emergency Dept. - HOPD in Hialeah, Florida.

Dr. Horvath's NPI, 1619366259, was assigned on January 20, 2015. Dr. Horvath graduated from Central University of Venezuela in 2007. Dr. Horvath holds Florida license ME136713.

Dr. Horvath's primary practice is Mount Sinai Medical Center - Hialeah Emergency Dept. - HOPD, at 6050 W 20th Ave, Hialeah, FL 33016.

Dr. Horvath's primary practice is Mount Sinai Medical Center - Hialeah Emergency Dept. - HOPD in Hialeah, Florida. Dr. Horvath is also affiliated with Mount Sinai Medical Center. The medical group on file is Mount Sinai Medical Center. Dmand AI also links Dr. Horvath to 1 more group practice or clinic, named with a free account. Dr. Horvath's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Horvath practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Horvath's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Horvath is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Horvath's licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart blockage, heart failure and heart valve disorders among the conditions Dr. Horvath treats.

CMS data shows 742 Medicare services from Dr. Horvath across 15 procedure codes in 2024, for 379 Medicare patients. Medicare paid $38,571 for them.

CMS counts 379 Medicare patients who saw Dr. Horvath in 2024. The largest group is 75 to 84, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Horvath's median patient age at 75, with 50% women.

In 2024, Dr. Horvath wrote 5,859 Medicare Part D claims for 745 patients. 76% of them were for generic drugs. CMS names the drug for 5,522 of them, across 58 drugs with 11 or more claims each, at $2,334,787 in total drug cost. In 2023, CMS named 2,767 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Horvath for performance year 2024, reported as part of a group. Dr. Horvath accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Horvath as offering telehealth.

Dmand AI links 30 papers to Dr. Horvath, published from 2013 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Echocardiography, Myocardial Infarction and Mitral Valve Insufficiency. Dr. Horvath has published most often in Am J Cardiol. Dr. Horvath's most frequent co-authors are Christos George Mihos, DO, Orlando Santana, MD and Orlando Santana, MD.

CMS Open Payments shows 577 general payments to Dr. Horvath from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Abbott Laboratories paid the most, $2,593.

Dr. Horvath graduated from Central University of Venezuela in 2007.

Dr. Horvath is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.